Latest News Releases From The Newsroom
Nikola Reveals Strategic Moves, MorphoSys Surges on Positive PT Revisions
June 16th, 2023
Nikola Corporation (Nasdaq: NKLA) has provided a progress update on its business optimization efforts, which aim to streamline operations and reduce cash spend. As part of these initiatives, the company conducted a thorough review of its organization. Read more
Nikola Strikes Back; Analysts Bullish on Jabil
June 16th, 2023
In a regulatory filing with the SEC, Nikola Corporation (Nasdaq: NKLA) has responded to a recent social media post by its former CEO, Trevor Milton, stating that it misstates the facts. According to the company, since Milton's departure in September . Read more
UK's CMA OKs Amazon's iRobot Purchase; Morgan Stanley PT Boosts NVIDIA, AMD, Adobe, Intel, Marvell
June 16th, 2023
The Competition and Markets Authority (CMA) in the UK has cleared Amazon.com, Inc.'s (Nasdaq: AMZN) $1.7 billion purchase of iRobot Corporation (Nasdaq: IRBT), the maker of Roomba robot vacuum cleaners. The CMA examined potential concerns re. Read more
Coherus BioSciences Is To Takeover Surface Oncology
June 16th, 2023
Coherus BioSciences, Inc. (Nasdaq: CHRS) and Surface Oncology, Inc. (Nasdaq: SURF) have entered into a definitive merger agreement where Coherus will acquire Surface Oncology in a stock for stock transaction valued at up to $65 million. This. Read more
Evelo Biosciences Granted U.S. Patent; Needham: Opportunity On DoubleVerify, and Clearfield
June 16th, 2023
Evelo Biosciences, Inc. (Nasdaq: EVLO), a biotechnology company, has been awarded U.S. Patent No. US 11,672,834 B2 by The United States Patent and Trademark Office (USPTO). The patent, titled "Probiotic and prebiotic compositions, and methods of u. Read more
Momentum Building: Reata Pharma, Virgin Galactic, Squarespace Make Key Announcements
June 16th, 2023
Reata Pharmaceuticals, Inc. (Nasdaq: RETA) made a significant announcement as the U.S. Food and Drug Administration (FDA) accepted the filing of the Prior Approval Supplement (PAS) for SKYCLARYS (omaveloxolone). This acceptance signifies tha. Read more
PT Hikes: Analysts See Upside for ALGT, GLW, VSTM, RAPT, AVAV, CWST, OMF, and XAIR
June 15th, 2023
Allegiant Travel Company (Nasdaq: ALGT), a leading low-cost airline based in the United States, received an upgrade from Deutsche Bank, shifting its rating from Hold to Buy and raising the price target from $110 to $145. With $ALGT closing a. Read more
Palantir's Subsidiary Strengthens Military Data Analysis with Contracts Totaling $110M+
June 15th, 2023
Palantir USG Inc., a subsidiary of Palantir Technologies Inc. (NYSE: PLTR), has been awarded a total of $110,454,815 in firm-fixed-price contracts for its Data-as-a-Service Platform solutions. These contracts, with Space Systems Command, Los Angeles . Read more
Adobe Shatters Estimates; PT Boosts for Omnicell, R1 RCM, and Shell
June 15th, 2023
Adobe Inc. (Nasdaq: ADBE), the renowned software company, has announced its financial results for the second quarter of fiscal year 2023. The company reported an impressive earnings per share (EPS) of $3.91, surpassing the consensus estimate of $3.79. Read more
VIQ Solutions Partners with JAVS; Altamira Therapeutics Gets FDA Green-Light; Kroger Reports Q1 Earnings
June 15th, 2023
VIQ Solutions Inc. (Nasdaq: VQS) has announced a strategic partnership with Justice AV Solutions (JAVS), a renowned global provider of court recording and AV services. This collaboration aims to revolutionize the legal profession by introducing AI-ge. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026




Member Login